NCT05780099 Prospective Observational Study to Characterize Patients Treated at Internal Medicine Clinics
| NCT ID | NCT05780099 |
| Status | Recruiting |
| Phase | — |
| Sponsor | IRCCS San Raffaele |
| Condition | Respiratory Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 50,000 participants |
| Start Date | 2022-06-24 |
| Primary Completion | 2031-09-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 50,000 participants in total. It began in 2022-06-24 with a primary completion date of 2031-09-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Patients referred to internal medicine wards are becoming increasingly complex and fragile. Despite deep knowledge of their specific disorders, steps are required to improve overall management of their acute and chronic conditions. The main objective of the study is to identify demographic, clinical, laboratory and radiological markers of disease severity and activity in patients with diseases treated at general medicine wards (respiratory disease, immune-mediated disease, sepsis, metabolic disease, rare disease, frailty, pregnancy pathology) in order to improve their diagnosis, monitoring and treatment processes.
Eligibility Criteria
Inclusion Criteria: * Receving treatment at internal medicine departments (inpatient, outopatient, day hospital) of San Raffaele Hospital * at least one suspected or confirmed diagnosis among: 1. immune mediated disorder 2. respiratory disorder 3. metabolic disorder 4. sepsis 5. rare disorder (according to Italian Ministry of Health list) 6. pregnancy-related disorder 7. frailty defined as: either ≥2 CIRS (Cumulative Illness Rating Scale) Severity Index 10 or ≤70% Karnofsky scale Exclusion Criteria: * refusal to participate * enrolment in other intervantional study
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05780099 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Respiratory Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05780099 currently recruiting?
Yes, NCT05780099 is actively recruiting participants. Contact the research team at rovere.patrizia@hsr.it for enrollment information.
Where is the NCT05780099 trial being conducted?
This trial is being conducted at Milan, Italy, Milan, Italy.
Who is sponsoring the NCT05780099 clinical trial?
NCT05780099 is sponsored by IRCCS San Raffaele. The trial plans to enroll 50,000 participants.